Actinium Pharmaceuticals Inc. sell Lokrim
Start price
13.11.23
/
20%
€4.12
Target price
13.11.24
-
Performance (%)
28.64%
End price
09.12.23
€5.30
Summary
This prediction ended on 09.12.23 with a price of €5.30. The prediction closed with a disappointing performance of 28.64%. Lokrim has a follow-up prediction for Actinium Pharmaceuticals Inc. where he still thinks Actinium Pharmaceuticals Inc. is a Sell. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Actinium Pharmaceuticals Inc. | 4.391% | 4.391% |
| iShares Core DAX® | -1.114% | 3.430% |
| iShares Nasdaq 100 | 1.816% | 6.911% |
| iShares Nikkei 225® | 2.113% | 5.501% |
| iShares S&P 500 | 2.038% | 5.327% |
According to Lokrim what are the pros and cons of Actinium Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
Risky Investment
Comments by Lokrim for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
Sell Actinium Pharmaceuticals Inc.
In the thread Trading Actinium Pharmaceuticals Inc.
Current prediction by Lokrim for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.63
17.08.24
17.08.24
-
17.08.25
17.08.25
3.75%
02.10.24
02.10.24
Revenue decline/stagnation expected
Risky Investment
Stopped prediction by Lokrim for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.69
09.12.23
09.12.23
-
09.12.24
09.12.24
-
11.12.23
11.12.23
Could be very worthwhile Investment >20% year